Subsequently, the effector T cells stimulated by these processes facilitate the release of interleukin (IL)-1β, IL-17, and interferon (IFN)-γ, which act as potent agents in mediating the direct eradication of tumor cells [35]. The gene discussed is IFNG; the disease is neoplasm.